by santereshealth | Mar 16, 2021 | CMP News
The draft screening assessment and risk management scope for the Thiophosphate Alkyl Esters Group was published for a 60-day public comment period ending on May 12, 2021. Available here
by santereshealth | Mar 16, 2021 | CMP News
The Draft Screening Assessment for Piperazine was published for a 60-day public comment period ending on May 12, 2021. Available here.
by santereshealth | Mar 16, 2021 | CMP News
The Draft Screening Assessment for the Ethers Group was published for a 60-day public comment period ending on May 12, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The draft screening assessment and risk management scope for the Aliphatic Amines Group was published for a 60-day public comment period ending on May 5, 2021. Available here.
by santereshealth | Mar 10, 2021 | CMP News
The draft screening assessment and risk management scope for the Benzotriazoles and Benzothizoles Group was published for a 60-day public comment period ending on May 5, 2021. Available here.
Recent Comments